Rep. Julie Johnson Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Representative Julie Johnson (D-Texas) sold shares of UnitedHealth Group stock worth between $1,001 and $15,000 on August 14th, as disclosed in a filing on September 11th.
• The stock declined 0.3% during mid-day trading, with a current trading price of $352.61, reflecting a significant drop from its 12-month high of $630.73.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, representing an annualized payout of $8.84 and a dividend yield of 2.5%.

Representative Julie Johnson (D-Texas) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on August 14th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Fidelity National Information Services NYSE: FIS on 8/14/2025.
• Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Dover NYSE: DOV on 8/14/2025.
• Sold $1,001 - $15,000 in shares of Texas Instruments NASDAQ: TXN on 8/14/2025.

UnitedHealth Group Stock Down 0.3%

NYSE:UNH traded down $1.00 during mid-day trading on Friday, hitting $352.61. The stock had a trading volume of 13,985,550 shares, compared to its average volume of 18,883,918. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a 50-day simple moving average of $291.98 and a two-hundred day simple moving average of $369.01. The company has a market capitalization of $319.35 billion, a PE ratio of 15.28, a PEG ratio of 2.31 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is currently 38.30%.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. HSBC restated a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Wolfe Research reduced their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Finally, Piper Sandler cut their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $358.95.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of UNH. Valeo Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 45.4% in the second quarter. Valeo Financial Advisors LLC now owns 20,173 shares of the healthcare conglomerate's stock valued at $6,293,000 after acquiring an additional 6,299 shares in the last quarter. Silicon Valley Capital Partners boosted its position in UnitedHealth Group by 14.8% during the second quarter. Silicon Valley Capital Partners now owns 4,043 shares of the healthcare conglomerate's stock worth $1,261,000 after acquiring an additional 522 shares during the last quarter. WT Wealth Management purchased a new position in shares of UnitedHealth Group during the 2nd quarter worth $2,435,000. NWF Advisory Services Inc. lifted its position in UnitedHealth Group by 306.6% during the second quarter. NWF Advisory Services Inc. now owns 2,468 shares of the healthcare conglomerate's stock worth $770,000 after buying an additional 1,861 shares during the period. Finally, Alternative Investment Advisors LLC. acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $1,260,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.